Omar Zaher

Forschungsgebiet

Physiologie-basierte Pharmakokinetik (PBPK) Modellierung

Lebenslauf

Seit 01/2024: Doktorand in der Klinischen Pharmazie, Universität des Saarlandes, Saarbrücken

06/2021 – 08/2021: Praktikum, Pharmacometrics research group, Universität Uppsala, Schweden

09/2020 – 08/2022: Master of pharmaceutical modeling, Universität Uppsala, Schweden

08/2018 – 08/2020: Senior product specialist, Sanofi Genzyme, Saudi-Arabien

06/2011 – 06/2018: Neurology product specialist, Biogen, Ägypten, Saudi-Arabien

01/2010 – 05/2011: Oncology medical representative, Hospira, Ägypten

09/2005 – 06/2009: Studium der Pharmazie, Alexandria University, Faculty of pharmacy, Ägypten

Publikationen

Manuskripte

Walle N, Dings C, Zaher O, Doerr AA, Peters B, Laschke MW, Lehr T, Menger MD, Schmidt PH, Meyer MR, Schaefer N. Does a carboxamide moiety alter the toxicokinetics of synthetic cannabinoids? A study after pulmonary and intravenous administration of cumyl-5F-P7AICA to pigs. Arch Toxicol. 2025. doi:10.1007/s00204-024-03906-z

Centanni M, Zaher O, Elhad D, Karlsson MO, Friberg LF. Physiologically-based pharmacokinetic models versus allometric scaling for prediction of tyrosine-kinase inhibitor exposure from adults to children. Cancer Chemother Pharmacol. 2024. doi:10.1007/s00280-024-04678-0